The Xerostomia Therapeutics Market is projected to grow at a CAGR of 3.8% during 2024–2031. Growth is driven by increasing prevalence of xerostomia due to factors like chemotherapy, radiotherapy, and autoimmune diseases. North America holds the largest market share, while Asia-Pacific is the fastest-growing region. https://www.datamintelligence.com/research-report/xerostomia-therapeutics-market?dr